Subscribe To
Outlook Therapeutics Announces $25 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
ISELIN, N.J., Dec. 23, 2022 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company working to develop and launch the first FDA-approved ophthalmic formulation of bevacizumab for use in retinal indications, today announced that it has entered into securities purchase agreements with existing institutional and accredited investors for the purchase and sale of […] The post Outlook Therapeutics Announces $25 Million Registered Direct Offering Priced At-the-Market U...
Read More
Content Topics
Outlook
Therapeutics
Announces
Million
Registered
Direct
Offering
Priced
At the market
Nasdaq
Forex
Posted: Dec 23 2022, 11:00
Author Name: forextv
Views: 102023